CH
China Medical System Holdings Limited
CHSYF · OTC
$1.57 +0.00% (+$0.00)
Market Cap ¥25.5B
P/E Ratio 17.56x
Div. Yield 2.80%
ROE 8.45%
Bulios Fair Price
$0.89
43.3% downside
Current Price
$1.57
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHSYF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
48 /100
Fair P/B 1.46x
P/S 3.18x
P/E 17.56x
Growth
6 /100
Declining Book val. growth 6.06%
FCF growth 56.81%
EPS growth 23.31%
Profitability
71 /100
Strong FCF margin 3.05%
Op. margin 19.22%
Gross margin 71.50%
Quality
39 /100
Average Asset turnover 0.42x
ROA 7.55%
ROIC 5.73%
Debt
100 /100
Low Net debt/EBITDA -1.12x
Int. coverage 77.77x
Debt/Equity 0.04x
Stability
92 /100
Stable Profitable years 6
EPS volatility 11.02%
Beta 1.08x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHSYF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kong Lam
Employees
6,415
Headquarters
Hong Kong
Upcoming events
16 MAR
Earnings
Upcoming earnings report